3,4-dihydroxyphenylacetic acid has been researched along with seglitide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cooper, J; Greenslade, RG; Mitchell, SN; Sharrott, A | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and seglitide
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Ventral subiculum administration of the somatostatin receptor agonist MK-678 increases dopamine levels in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Hypothalamus; Male; Nucleus Accumbens; Peptides, Cyclic; Rats; Receptors, Somatostatin; Time Factors | 2000 |